|
Nervous System Functions of Poly(ADP-Ribose) Polymerase-1 |
|
|
1 | (18) |
|
|
|
|
|
|
|
Role of Poly(ADP-Ribose) Polymerase-1 in Neurologic Disorders |
|
|
19 | (20) |
|
|
|
|
|
|
|
Involvement of PARP-1 and Poly(ADP-Ribosyl)ation in the Maintenance of Genomic Stability |
|
|
39 | (28) |
|
Cynthia M. Simbulan-Rosenthal |
|
|
|
|
|
|
|
|
|
|
|
|
Functional Testing of Human PARP in Proliferation, Endotoxic Shock, and Radiosensitivity: A Genetic Rescue Study |
|
|
67 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
PARP Inhibitors as Neuroprotective Agents for Brain Injury |
|
|
83 | (34) |
|
|
|
|
|
|
|
PARP Inhibitors and Cardioprotection |
|
|
117 | (18) |
|
|
|
|
|
|
|
|
|
Neuroprotection of the Retina with 3-Aminobenzamide, a PARP Inhibitor |
|
|
135 | (14) |
|
|
|
Poly(ADP-Ribose) Polymerase Inhibitors and Acute Renal Failure |
|
|
149 | (20) |
|
|
|
|
|
Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Shock and Inflammation |
|
|
169 | (36) |
|
|
|
Clinical Development of the Nicotinamides and Benzamides Involving PARP as a Molecular Target |
|
|
205 | (18) |
|
|
|
|
|
|
|
|
|
Chemoprotective Effect of a Novel PARP Inhibitor |
|
|
223 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beneficial Effect of GPI 6150 Treatment in Multiple Animal Models of Diseases |
|
|
239 | (18) |
|
|
|
Protecting Effect of PARP Inhibition on Ultraviolet Light-Induced Skin Damage |
|
|
257 | (20) |
|
|
|
|
|
Gyorgy Rabloczky Bela Csete |
|
|
|
|
|
|
|
|
|
|
Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Diabetes Mellitus and Diabetic Vascular Dysfunction |
|
|
277 | (44) |
|
|
|
|
|
|
|
Therapeutic Targeting of the PARPs: Future Challenges, Future Opportunities |
|
|
321 | (8) |
|
|
|
|
| Index |
|
329 | |
Shopping Cart
